Main Menu
Menu

Addressing Patent Myths

Publish Date
Resources
Issue Briefs
Addressing Patent Myths

Activist groups routinely accuse companies of “abusing” the patent system by engaging in practices such as “royalty stacking,” “patent evergreening,” “product hopping,”...

Resources
Infographics & Fact Sheets
Myths vs. Facts: Terminal Disclaimers
Resources
Infographics & Fact Sheets
Myths vs. Facts: The Eliminating Thickets to Increase Competition (ETHIC) Act
Blog
Why C4IP Opposes the ETHIC Act (S. 2276)

The Eliminating Thickets to Increase Competition (ETHIC) Act aims to eliminate so-called “patent thickets” in the prescription drug market — when companies...

BlogFact Checks
Fact Check: Debunking the Patent “Evergreening” Myth

On April 16, the R Street Institute hosted a congressional briefing entitled “The Hidden Tax: How Bad Patents Drive Up Drug Prices...

BlogFact Checks
Fact Check: The ETHIC Act Targets a Problem That Doesn’t Exist

Congress is considering a bill, the Eliminating Thickets to Increase Competition (ETHIC) Act, that would undermine innovation by preventing patent owners from...

Blog
Debunking common myths in the SEP patent pool debate

Patent pools are a time-tested approach to licensing standard-essential patents, also known as SEPs. These collaborative arrangements allow implementers to conveniently obtain...

BlogFact Checks
Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”

Former Federal Trade Commission Chair Lina Khan recently appeared on The Weekly Show with Jon Stewart, where their discussion revived familiar tropes...

BlogFact Checks
Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

BlogFact Checks
Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology
Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences
Resources:

Resources:

Myths vs. Facts: Terminal Disclaimers,

05/29/2026
Resources:

Resources:

Myths vs. Facts: The Eliminating Thickets to Increase Competition (ETHIC) Act,

05/29/2026
Blog:

Blog:

Why C4IP Opposes the ETHIC Act (S. 2276),

05/29/2026
Blog:

Blog, Fact Checks:

Fact Check: Debunking the Patent “Evergreening” Myth,

05/28/2026
Blog:

Blog, Fact Checks:

Fact Check: The ETHIC Act Targets a Problem That Doesn’t Exist,

04/17/2026
Blog:

Blog:

Debunking common myths in the SEP patent pool debate,

01/28/2026
Blog:

Blog, Fact Checks:

Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”,

01/16/2026
Blog:

Blog, Fact Checks:

Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.,

12/04/2025
Blog:

Blog, Fact Checks:

Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”,

11/21/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025
Blog:

Blog, Fact Checks:

Fact Check: PERA and the PREVAIL Act Would Bolster, Not Harm, Inventors,

06/18/2025
Scroll to Top